Klaus Bitsch-Jensen

Klaus Bitsch-Jensen has extensive experience in pharmacovigilance and regulatory affairs, currently serving as Director, Head of QPPV Office & EU-QPPV at ALK since May 2019. Prior roles at ALK include Head of QPPV Office and Deputy EU-QPPV, along with serving as a Global Safety Compliance Specialist at Novo Nordisk from May 2015 to April 2019. Earlier career experience includes positions as a Scientific PV Adviser and Drug Safety Adviser at ALK Abelló and a Consultant at A-consult a/s focused on regulatory affairs and sales. Klaus Bitsch-Jensen holds a Master's degree from Danmarks Farmaceutiske Universitet and completed further studies at Copenhagen Business School.